Blood News and Research

RSS

Antibiotic minocycline might help alleviate HIV's negative effects on the brain and central nervous system

By studying animals, Johns Hopkins researchers have discovered that the antibiotic minocycline might help alleviate HIV's negative effects on the brain and central nervous system, problems that can develop even though antiretroviral therapy controls the virus elsewhere in the body.

1 May 2005

British court gives the go ahead for IVF babies to be created to save sick siblings

Britain's highest appeal court has rejected a challenge from an anti-abortion group and has backed a 2003 Court of Appeal ruling that some couples undergoing the fertility treatment could have their embryos screened to find tissue matches for seriously ill children. The procedure will help save desperately ill children but some fear it could lead to the creation of babies for spare parts

1 May 2005

Study shows genes predict how well diabetes drug will work

How well a person with type 2 diabetes responds to a diabetes drug may well depend upon his or her genetic make-up, according to a study published in the May issue of Diabetes Care. The study found that people who carried certain genotypes responded less favorably to rosiglitazone, a drug often prescribed for people with diabetes, than carriers of other genotypes.

28 Apr 2005

Research may re-define management of heart failure in diabetes

Control of oxidised copper levels in the body may be as important as lowering blood glucose levels in preventing cardiovascular complications in diabetes mellitus, according to New Zealand researchers.

28 Apr 2005

Trial to evaluate modern stent technologies over balloon angioplasty for peripheral arterial disease

The first patient undergoes treatment today in a new prospective randomised trial, called the SUPER Study, to compare stenting with balloon angioplasty in patients with superficial femoral artery (SFA) occlusions caused by peripheral artery disease (PAD).

28 Apr 2005

Potential for brain stem cells to be used to cure diabetes

Promising new research by US scientists has shown the potential for brain stem cells to be used to cure diabetes. The work by Stanford University researchers, though not yet ready to be tested on human patients, has shown promising results in animals.

28 Apr 2005

Ginkgo beneficial for multiple sclerosis symptoms

When it comes to her health, Janice Winfield of Portland, Ore., does her research. That's why the stay-at-home mom, who was diagnosed with multiple sclerosis in July 2000, was willing to turn to popular, over-the-counter herbal supplements like ginkgo biloba to deal with memory problems, fatigue and occasional muscle pain.

27 Apr 2005

Just in case you thought it was safe to fly!

Just in case you were not already too scared to fly, a study by a team at Belfast University and Hospital now tells us that most air passengers are risking their health flying by being starved of oxygen.

27 Apr 2005

Australian clinical trial of potent new anticancer drug (CYT997)

Up to 30 patients with advanced incurable solid-tumours are to be involved in clinical trials of a potent new anticancer drug (CYT997), developed by Australian biotechnology company, Cytopia Limited.

27 Apr 2005

Asians and Pacific Islanders have the highest levels of iron in their blood

UAB and international scientists studying iron-overload disorders have made the unexpected discovery that Asians and Pacific Islanders have the highest levels of iron in their blood of all racial/ethnic groups who were screened.

27 Apr 2005

Sleeping too little or too much may increase risk of diabetes

A new report says that people who sleep for less than six hours or for more than nine hours each night may have an increased risk of diabetes and impaired blood sugar (glucose) tolerance.

27 Apr 2005

Risk scores identify young people with hardened arteries

Armed with more knowledge about what cardiovascular disease looks like in people ages 15 to 34, co-authors from the University of Texas Health Science Center, the Southwest Foundation for Biomedical Research and institutions in Delaware, New York, Pennsylvania and Louisiana will report...

27 Apr 2005

Runners must hydrate properly

Seeking to clarify complex issues involving hydration for athletes, the American College of Sports Medicine (ACSM) today reiterated its statements on hyponatremia and dehydration for athletes during endurance events.

27 Apr 2005

Menopause and African-American women

A study of African–American women in menopause shows that while they experience many of the same symptoms as white women, they report more vasomotor symptoms such as dizziness and bloating, according to a study by a Yale School of Nursing researcher.

27 Apr 2005

Natural glucose byproduct prevents brain damage and cognitive impairment after diabetic coma

A natural, non-toxic byproduct of glucose may prevent brain cell death and cognitive impairment in diabetics following an episode of severely low blood sugar, according to researchers at the San Francisco VA Medical Center (SFVAMC).

27 Apr 2005

Patients' lives at risk from substandard drugs say heart specialists

Global action is needed to counter the dangers of substandard life-saving drugs that are putting patients' lives and health at risk, according to heart specialists writing in the new (19 April) issue of Europe's leading cardiology journal, the European Heart Journal.

27 Apr 2005

Increased risk associated with combining carotid artery, coronary artery surgeries

Among patients undergoing evaluation for coronary artery bypass surgery, stroke neurologists are frequently consulted when the patient also has severe carotid artery stenosis (blockage of an artery that supplies blood to the brain).

27 Apr 2005

Moderate hypothermia is a safe treatment following traumatic brain injury in children

A first-of-its-kind multi-center trial has shown that cooling the body can have positive affects on children who suffered traumatic brain injury.

27 Apr 2005

National clinical trial examines new option for kidney cancer patients

The trial, which opened last September, offers research subjects who qualify a new, targeted therapy in addition to standard immune therapy. The drug combination is being studied in a national Phase II clinical trial led by OHSU Cancer Institute researcher Christopher Ryan, M.D., through the Southwest Oncology Group, one of the largest clinical trial cooperative groups in the United States.

27 Apr 2005

Alcohol-impaired driving on the increase

A national survey has found that after a long, slow downward trend alcohol-impaired driving has recently increased significantly. From 1993 to 1997 the estimated annual number of episodes of alcohol-impaired driving (AID) declined at a rate of a little more than one percent per year, from 123 million to 116 million.

27 Apr 2005